CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cell (In Press)
Original article

The structural basis for LRRK2’s activation and autoinhibition

Positive
AI Analysis

Summary

Study reveals structural basis for LRRK2 activation and autoinhibition, showing how the ROC GTPase acts as a molecular switch regulating kinase activity linked to Parkinson's disease and how certain PD mutations disrupt this regulatory mechanism.

Importance:2/10
Sentiment:
0.30
LRRK2Parkinson's diseasekinase inhibitionstructural biologyresearch
Related Companies

Read the original article

Published by Cell (In Press) on August 10, 2026 12:00 AM

Read Original